EDGAR Filing Documents for 0001144204-13-044927

Form 8-K - Current report:

SEC Accession No. 0001144204-13-044927

Filing Date

2013-08-13

Accepted

2013-08-13 09:31:24

Documents

Period of Report

2013-08-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K CURRENT REPORT	v352787_8k.htm	8-K	22433
2	EXHIBIT 1.1	v352787_ex1-1.htm	EX-1.1	186953
3	EXHIBIT 4.1	v352787_ex4-1.htm	EX-4.1	129805
4	EXHIBIT 99.1	v352787_ex99-1.htm	EX-99.1	5939
	Complete submission text file	0001144204-13-044927.txt		346599

Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158

Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188

BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)